177 related articles for article (PubMed ID: 23279149)
1. Marked improvement in delirium with ramelteon: five case reports.
Furuya M; Miyaoka T; Yasuda H; Yamashita S; Tanaka I; Otsuka S; Wake R; Horiguchi J
Psychogeriatrics; 2012 Dec; 12(4):259-62. PubMed ID: 23279149
[TBL] [Abstract][Full Text] [Related]
2. [Delirium, insomnia in hospitalization and ramelteon].
Ito T
Nihon Rinsho; 2012 May; 70(5):907-13. PubMed ID: 22620020
[TBL] [Abstract][Full Text] [Related]
3. Ramelteon for the treatment of delirium in elderly patients: a consecutive case series study.
Tsuda A; Nishimura K; Naganawa E; Otsubo T; Ishigooka J
Int J Psychiatry Med; 2014; 47(2):97-104. PubMed ID: 25084796
[TBL] [Abstract][Full Text] [Related]
4. Melatonin receptor agonists for treating delirium in elderly patients with acute stroke.
Ohta T; Murao K; Miyake K; Takemoto K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1107-10. PubMed ID: 23017429
[TBL] [Abstract][Full Text] [Related]
5. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.
Baño Otalora B; Popovic N; Gambini J; Popovic M; Viña J; Bonet-Costa V; Reiter RJ; Camello PJ; Rol MÁ; Madrid JA
Chronobiol Int; 2012 Aug; 29(7):822-34. PubMed ID: 22823866
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.
Hatta K; Kishi Y; Wada K; Takeuchi T; Odawara T; Usui C; Nakamura H;
JAMA Psychiatry; 2014 Apr; 71(4):397-403. PubMed ID: 24554232
[TBL] [Abstract][Full Text] [Related]
7. Treatment of delirium with ramelteon: initial experience in three patients.
Kimura R; Mori K; Kumazaki H; Yanagida M; Taguchi S; Matsunaga H
Gen Hosp Psychiatry; 2011; 33(4):407-9. PubMed ID: 21762839
[TBL] [Abstract][Full Text] [Related]
8. Successfully treated delirium in an extremely elderly patient by switching from risperidone to ramelteon.
Tsuda A; Nishimura K; Naganawa E; Otsubo T; Ishigooka J
Psychiatry Clin Neurosci; 2013 Feb; 67(2):130. PubMed ID: 23438172
[No Abstract] [Full Text] [Related]
9. Novel Therapy With Ramelteon for Hypoactive Delirium: A Case Report.
Miura S; Furuya M; Yasuda H; Miyaoka T; Horiguchi J
J Clin Psychopharmacol; 2015 Oct; 35(5):616-8. PubMed ID: 26114404
[No Abstract] [Full Text] [Related]
10. Melatonin and melatonin agonist for delirium in the elderly patients.
Chakraborti D; Tampi DJ; Tampi RR
Am J Alzheimers Dis Other Demen; 2015 Mar; 30(2):119-29. PubMed ID: 24946785
[TBL] [Abstract][Full Text] [Related]
11. Ramelteon is Not Associated With Improved Outcomes Among Critically Ill Delirious Patients: A Single-Center Retrospective Cohort Study.
Thom R; Bui M; Rosner B; Teslyar P; Levy-Carrick N; Wolfe D; Klompas M
Psychosomatics; 2019; 60(3):289-297. PubMed ID: 30193784
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant effects of the selective melatonin receptor agonist ramelteon.
Fenoglio-Simeone K; Mazarati A; Sefidvash-Hockley S; Shin D; Wilke J; Milligan H; Sankar R; Rho JM; Maganti R
Epilepsy Behav; 2009 Sep; 16(1):52-7. PubMed ID: 19682955
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and Ramelteon for the treatment of delirium: A systematic review and meta-analysis.
Beaucage-Charron J; Rinfret J; Coveney R; Williamson D
J Psychosom Res; 2023 Jul; 170():111345. PubMed ID: 37150157
[TBL] [Abstract][Full Text] [Related]
14. Melatonin Receptor Agonists for Delirium Prevention.
Walker CK; Gales MA
Ann Pharmacother; 2017 Jan; 51(1):72-78. PubMed ID: 27539735
[TBL] [Abstract][Full Text] [Related]
15. Delirium: a disturbance of circadian integrity?
Fitzgerald JM; Adamis D; Trzepacz PT; O'Regan N; Timmons S; Dunne C; Meagher DJ
Med Hypotheses; 2013 Oct; 81(4):568-76. PubMed ID: 23916192
[TBL] [Abstract][Full Text] [Related]
16. Ramelteon as adjunctive therapy for delirium referred to a consultation-liaison psychiatry service: a retrospective analysis.
Furuya M; Miyaoka T; Yasuda H; Wake R; Hashioka S; Miura S; Nagahama M; Araki T; Horiguchi J
Int J Geriatr Psychiatry; 2015 Sep; 30(9):994-5. PubMed ID: 26220878
[No Abstract] [Full Text] [Related]
17. Effects of ramelteon on refractory behavioral and psychological symptoms of dementia in Alzheimer disease.
Asano M; Ishitobi M; Tanaka Y; Wada Y
J Clin Psychopharmacol; 2013 Aug; 33(4):579-81. PubMed ID: 23764686
[No Abstract] [Full Text] [Related]
18. Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats.
Hirai K; Kita M; Ohta H; Nishikawa H; Fujiwara Y; Ohkawa S; Miyamoto M
J Biol Rhythms; 2005 Feb; 20(1):27-37. PubMed ID: 15654068
[TBL] [Abstract][Full Text] [Related]
19. Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients.
Mo Y; Scheer CE; Abdallah GT
J Intensive Care Med; 2016 Aug; 31(7):451-5. PubMed ID: 26092575
[TBL] [Abstract][Full Text] [Related]
20. [A nationwide survey on the uses of melatonin and ramelteon in Japanese children].
Fukumizu M; Hayashi M; Miyajima T; Ishizaki A; Tanaka H; Kohyama J
No To Hattatsu; 2015 Jan; 47(1):23-7. PubMed ID: 25803907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
